Finasteride Reduces Risk of Bladder Cancer in a Large Prospective Screening Study
- 1 March 2016
- journal article
- research article
- Published by Elsevier in European Urology
- Vol. 69 (3) , 407-410
Abstract
No abstract availableKeywords
This publication has 6 references indexed in Scilit:
- Androgen deprivation therapy prevents bladder cancer recurrenceOncotarget, 2014
- Epidermal growth factor enhances androgen receptor-mediated bladder cancer progression and invasion via potentiation of AR transactivationOncology Reports, 2013
- Decreased Tumorigenesis and Mortality from Bladder Cancer in Mice Lacking Urothelial Androgen ReceptorThe American Journal of Pathology, 2013
- Androgen Receptor Is a Potential Therapeutic Target for Bladder CancerUrology, 2010
- Mortality Results from a Randomized Prostate-Cancer Screening TrialNew England Journal of Medicine, 2009
- The Influence of Finasteride on the Development of Prostate CancerNew England Journal of Medicine, 2003